Enovis (ENOV) Cash & Current Investments (2010 - 2026)
Enovis' (ENOV) quarterly Cash & Current Investments came in at $12.6 million in Q3 2026, down 71.5% year-over-year from $44.1 million in Q3 2025, and down 62.08% quarter-over-quarter from $33.1 million in Q2 2026.
Analysis
Enovis (ENOV) Cash & Current Investments (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Cash & Current Investments for 17 consecutive years, with $12.6 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Cash & Current Investments fell 71.5% year-over-year to $12.6 million in Q3 2026; TTM through Jul 2026 was $12.6 million, a 71.5% decrease from a year earlier, with the FY2025 full-year figure at $36.4 million, down 24.45% from the prior year.
- Cash & Current Investments was $12.6 million for Q3 2026 at Enovis, down from $33.1 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $661.5 million in Q2 2022 and troughed at $12.6 million in Q3 2026.
- A 5-year average of $100.3 million and a median of $35.8 million in 2023 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments soared 475.69% in 2022 and plunged 96.69% in 2023, its largest moves.
- Over 5 years, Cash & Current Investments stood at $24.3 million in 2022, then surged by 48.96% to $36.2 million in 2023, then surged by 33.09% to $48.2 million in 2024, then declined by 24.45% to $36.4 million in 2025, then plunged by 65.48% to $12.6 million in 2026.
- The last three Cash & Current Investments figures came in at $12.6 million (Q3 2026), $33.1 million (Q2 2026), and $36.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 12.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 12.56 Mn |
| Apr 3, 2026 | 33.13 Mn |
| Dec 31, 2025 | 36.39 Mn |
| Oct 3, 2025 | 33.62 Mn |
| Jul 4, 2025 | 44.07 Mn |
| Apr 4, 2025 | 38.46 Mn |
| Dec 31, 2024 | 48.17 Mn |
| Sep 27, 2024 | 35.43 Mn |
| Jun 28, 2024 | 35.00 Mn |
| Mar 29, 2024 | 66.27 Mn |
| Dec 31, 2023 | 36.19 Mn |
| Sep 29, 2023 | 32.13 Mn |
| Jun 30, 2023 | 32.49 Mn |
| Mar 31, 2023 | 21.90 Mn |
| Dec 31, 2022 | 24.30 Mn |
| Sep 30, 2022 | 255.23 Mn |
| Jul 1, 2022 | 358.71 Mn |
| Apr 1, 2022 | 661.50 Mn |
| Dec 31, 2021 | 680.25 Mn |
| Oct 1, 2021 | 177.48 Mn |